loading
Organigram Global Inc stock is traded at $2.01, with a volume of 2.08M. It is down -0.99% in the last 24 hours and up +33.11% over the past month. Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
See More
Previous Close:
$2.03
Open:
$2.07
24h Volume:
2.08M
Relative Volume:
2.41
Market Cap:
$270.27M
Revenue:
$108.81M
Net Income/Loss:
$-186.70M
P/E Ratio:
-2.3872
EPS:
-0.842
Net Cash Flow:
$-16.83M
1W Performance:
+4.69%
1M Performance:
+33.11%
6M Performance:
+52.27%
1Y Performance:
+37.67%
1-Day Range:
Value
$2.01
$2.15
1-Week Range:
Value
$1.49
$2.24
52-Week Range:
Value
$0.85
$2.24

Organigram Global Inc Stock (OGI) Company Profile

Name
Name
Organigram Global Inc
Name
Phone
-
Name
Address
-
Name
Employee
1,150
Name
Twitter
@discoverogi
Name
Next Earnings Date
2024-08-13
Name
Latest SEC Filings
Name
OGI's Discussions on Twitter

Compare OGI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
OGI
Organigram Global Inc
2.01 272.96M 108.81M -186.70M -16.83M -0.842
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
122.24 54.10B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.90 46.85B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.90 43.82B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
30.35 34.79B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
517.13 21.83B 3.08B 1.24B 1.07B 25.61

Organigram Global Inc Stock (OGI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-17-24 Resumed Canaccord Genuity Speculative Buy
Apr-15-24 Upgrade Alliance Global Partners Neutral → Buy
Jan-13-23 Upgrade Stifel Hold → Buy
Jan-12-22 Upgrade Canaccord Genuity Hold → Speculative Buy
May-11-21 Upgrade CIBC Sector Underperform → Neutral
Apr-14-21 Downgrade CIBC Neutral → Sector Underperform
Apr-08-21 Upgrade BMO Capital Markets Underperform → Market Perform
Mar-10-21 Downgrade BMO Capital Markets Market Perform → Underperform
Jan-13-21 Downgrade Alliance Global Partners Buy → Neutral
Jan-13-21 Downgrade Canaccord Genuity Speculative Buy → Hold
Jul-07-20 Initiated Alliance Global Partners Buy
Jan-15-20 Upgrade Raymond James Mkt Perform → Outperform
Jan-13-20 Initiated BofA/Merrill Underperform
Jan-09-20 Downgrade Raymond James Outperform → Mkt Perform
Nov-12-19 Downgrade BMO Capital Markets Outperform → Market Perform
Nov-05-19 Initiated Cantor Fitzgerald Overweight
Oct-11-19 Upgrade Jefferies Hold → Buy
View All

Organigram Global Inc Stock (OGI) Latest News

pulisher
Dec 20, 2025

Is Organigram Global Inc. (0OG) stock undervalued after correctionWeekly Trading Summary & Weekly Market Pulse Alerts - ulpravda.ru

Dec 20, 2025
pulisher
Dec 19, 2025

Why Organigram Global Inc. (0OG) stock could break out in 20252025 Stock Rankings & Momentum Based Trading Ideas - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? - Seeking Alpha

Dec 19, 2025
pulisher
Dec 19, 2025

Why retail investors pile into Organigram Global Inc. stock2025 Volume Leaders & Technical Buy Zone Confirmation - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

How Organigram Global Inc. stock benefits from tech adoptionMarket Performance Report & Technical Pattern Based Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Organigram Global Inc. stock benefit from AI adoption2025 Geopolitical Influence & Reliable Price Action Trade Plans - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Organigram Global Inc. (TSE:OGI) Soars 33% But It's A Story Of Risk Vs Reward - simplywall.st

Dec 19, 2025
pulisher
Dec 18, 2025

Is Organigram Global Inc. stock attractive for hedge fundsQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Organigram Global (OGI) Leads Cannabis Stocks Amid Market Shift - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

SA Quant ranks cannabis stocks as Trump signs rescheduling order - MSN

Dec 18, 2025
pulisher
Dec 18, 2025

This analyst still loves Organigram - Cantech Letter

Dec 18, 2025
pulisher
Dec 18, 2025

Organigram Global (TSX:OGI) Shares Surge After TSX Smallcap Index Rally - Kalkine Media

Dec 18, 2025
pulisher
Dec 18, 2025

Reform Momentum Builds as Organigram Delivers Record Results - The Dales Report

Dec 18, 2025
pulisher
Dec 18, 2025

Aug Ideas: Will Organigram Global Inc. (0OG) stock extend growth storyPortfolio Growth Summary & Capital Protection Trade Alerts - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Hedge Fund Moves: Is Organigram Global Inc. stock oversold or undervaluedJuly 2025 WrapUp & Weekly Market Pulse Updates - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

Why Organigram (TSX:OGI) Is Up 27.1% After Strong FY2025 Results And Bullish 2026 Revenue Guidance - simplywall.st

Dec 17, 2025
pulisher
Dec 17, 2025

Organigram Global Inc (NASDAQ:OGI) Market Share Maintained - FXDailyReport.Com

Dec 17, 2025
pulisher
Dec 17, 2025

Organigram Global (TSX:OGI): Reassessing Valuation After Strong 2025 Results and Upbeat 2026 Guidance - Yahoo Finance

Dec 17, 2025
pulisher
Dec 16, 2025

OrganiGram: Fiscal Q4 Earnings Snapshot - New Haven Register

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global : INVESTOR PRESENTATION (25288d c535f6aa) - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global Inc (OGI) Q4 2025 Earnings Call Highlights: Record Revenue and Market ... - Yahoo Finance

Dec 16, 2025
pulisher
Dec 16, 2025

Cannabis Stocks To Follow TodayDecember 11th - MarketBeat

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global (TSX:OGI) Valuation Check Ahead TSX Smallcap Index Update - Kalkine Media

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram’s net revenue climbs in 2025, fuelled by domestic and international sales - StratCann

Dec 16, 2025
pulisher
Dec 16, 2025

OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates - sharewise.com

Dec 16, 2025
pulisher
Dec 16, 2025

Earnings call transcript: OrganiGram Q4 2025 sees revenue surge, stock up premarket - Investing.com Nigeria

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Q4 Net Loss Widens, Revenue Jumps - 富途牛牛

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global Inc. 2025 Q4ResultsEarnings Call Presentation (TSX:OGI:CA) 2025-12-16 - Seeking Alpha

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global : Financial Statements (dad9ab e585ce78) - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

OGI: Record revenue, margin gains, and global expansion position for strong 2026 growth - TradingView — Track All Markets

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Global (OGI) Reports Increased Q4 Net Loss Despite Re - GuruFocus

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram (OGI) Reports Strong Q4 with Strategic Global Expansi - GuruFocus

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Achieves Record Financial Results and Expands Market Leadership - TipRanks

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Brief: Q4 Net Loss Increased to $38.0 Million - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

Organigram Brief: Q4 Net Revenue $80.1 million - marketscreener.com

Dec 16, 2025
pulisher
Dec 16, 2025

Press Release: Organigram Reports Record Fourth Quarter and Fiscal 2025 Results - 富途牛牛

Dec 16, 2025
pulisher
Dec 15, 2025

Pre-Market Earnings Report for December 16, 2025 : OGI, DLTH - Nasdaq

Dec 15, 2025
pulisher
Dec 15, 2025

A Glimpse of OrganiGram Holdings's Earnings Potential - Benzinga

Dec 15, 2025
pulisher
Dec 14, 2025

Organigram (OGI) Set for Significant Revenue Growth in FQ4 - GuruFocus

Dec 14, 2025
pulisher
Dec 13, 2025

Peak Processing secures key agreement with Organigram for THC beverages - MSN

Dec 13, 2025
pulisher
Dec 13, 2025

Even after rising 16% this past week, Organigram Global (TSE:OGI) shareholders are still down 63% over the past five years - simplywall.st

Dec 13, 2025
pulisher
Dec 13, 2025

Wall Street Zen Upgrades Organigram Global (NASDAQ:OGI) to Hold - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Cannabis stocks surge after reports of Trump planning to ease federal restrictions - Yahoo! Finance Canada

Dec 12, 2025
pulisher
Dec 12, 2025

Trump Reportedly Plans Major Shift To Ease Federal Marijuana Rules - Benzinga

Dec 12, 2025
pulisher
Dec 11, 2025

Peak Processing Secures Key Agreement with Organigram for THC Beverages - TipRanks

Dec 11, 2025
pulisher
Dec 09, 2025

Organigram Global (OGI) Projected to Post Earnings on Tuesday - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Organigram Inc. Names James Yamanaka as CEO - Prepared Foods magazine

Dec 08, 2025
pulisher
Dec 08, 2025

Is Organigram Global Stock Built to Withstand a Pullback? - Trefis

Dec 08, 2025
pulisher
Dec 07, 2025

Is Organigram Global Inc a good long term investmentHealthcare Stock Analysis & Low Cost Wealth Building - earlytimes.in

Dec 07, 2025
pulisher
Dec 07, 2025

Organigram appoints new CEO to drive global growth - MSN

Dec 07, 2025

Organigram Global Inc Stock (OGI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RGC
$19.81
price up icon 4.70%
$22.30
price up icon 0.95%
drug_manufacturers_specialty_generic RDY
$14.18
price up icon 1.72%
$11.93
price down icon 0.08%
$145.00
price up icon 2.23%
$517.13
price up icon 2.00%
Cap:     |  Volume (24h):